Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of SWI/SNF Protein Expression by Immunohistochemistry in Ovarian Clear Cell Carcinoma.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists - 1 Mar 2021

Bennett Jennifer A, Safdar Nida, Segal Jeremy P, Lastra Ricardo R, Oliva Esther

Abstract excerpt

Ovarian clear cell carcinomas (OCCC) are known to harbor ARID1A mutations, and several recent studies have described immunohistochemical loss of SMARCA2, SMARCA4, and SMARCB1 in a subset of tumors. We performed ARID1A, SMARCA2, SMARCA4, and SMARCB1 immunohistochemistry on 105 OCCCs to identify possible associations with clinicopathologic features and assess their prognostic value in these tumors. ARID1A, SMARCA4,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Clear Cell
Share to DNA-Binding Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Helicases

Share to Immunohistochemistry

Share to Nuclear Proteins

Share to Ovarian Neoplasms

Share to SMARCB1 Protein

Share to Tissue Array Analysis

Source

Identifiers

PMID: 32897960
DOI: 10.1097/PGP.0000000000000687

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of SWI/SNF Protein Expression by Immunohistochemistry in Ovarian Clear Cell Carcinoma.PMID 32897960Read ↗

Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma.Semantic proximity Read ↗

ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell CarcinomaSemantic proximity Read ↗

Clinicopathological significance of loss of ARID1A immunoreactivity in ovarian clear cell carcinoma.Semantic proximity Read ↗

Does the Loss of ARID1A (BAF-250a) Expression in Endometrial Clear Cell Carcinomas Have Any Clinicopathologic Significance? A Pilot AssessmentSemantic proximity Read ↗

Treatment Strategies for ARID1A-Deficient Ovarian Clear Cell CarcinomaSemantic proximity Read ↗

SWI/SNF Complexes in Ovarian Cancer: Mechanistic Insights and Therapeutic Implications.Semantic proximity Read ↗

Aberrant SWI/SNF Complex Members Are Predominant in Rare Ovarian Malignancies—Therapeutic Vulnerabilities in Treatment-Resistant SubtypesSemantic proximity Read ↗

Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations and ZNF217 amplification in ovarian clear cell carcinoma.Semantic proximity Read ↗

The target therapy of ovarian clear cell carcinomaSemantic proximity Read ↗

ARID1A mutations in endometriosis-associated ovarian carcinomas.Semantic proximity Read ↗

Ovarian Clear Cell Carcinoma Sub-Typing by ARID1A Expression.Semantic proximity Read ↗

Molecular pathogenesis of ovarian clear cell carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.